Recall of Device Recall MIRA

According to U.S. Food and Drug Administration, this recall involved a device in United States that was produced by Roche Diagnostics Corp..

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
  • Event ID
  • Event Risk Class
    Class 3
  • Event Number
  • Event Initiated Date
  • Event Date Posted
  • Event Status
  • Event Country
  • Event Terminated Date
  • Event Source
  • Event Source URL
  • Notes / Alerts
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Extra notes in the data
    Assay, Glycosylated Hemoglobin - Product Code LCP
  • Reason
    The product is not uniform across the cassettes of some lots, which will result in an inconsistent bias of patient results.
  • Action
    Recall letters dated 2/15/05 were sent to each user instructing customers to run controls before the use of each cassette or kit in a lot, instead of once per lot as previously instructed, and to notify the physician at the facility.


  • Model / Serial
    Lots 646340, 650984, 651640 and 653292.
  • Product Classification
  • Device Class
  • Implanted device?
  • Distribution
  • Product Description
    Roche ULTIMATE 3 HBA1C test kit for use with MIRA analyzers; catalog number 20755648322.
  • Manufacturer


  • Manufacturer Address
    Roche Diagnostics Corp., 9115 Hague Rd, Indianapolis IN 46256-1025
  • Source